EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS
El Mulla, K., Agamiaa, N., Ghazala, R., Ahmed Zaki, I., Moharram Sabbah, R. (2022). EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS. EKB Journal Management System, 4(1), 16-17. doi: 10.21608/alexpo.2022.116795.1349
Khaled Fawzy El Mulla; Naglaa Fathi Agamiaa; Rasha Abd El Mawla Ghazala; Inass Ibrahim Ahmed Zaki; Rana Mahmoud Moharram Sabbah. "EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS". EKB Journal Management System, 4, 1, 2022, 16-17. doi: 10.21608/alexpo.2022.116795.1349
El Mulla, K., Agamiaa, N., Ghazala, R., Ahmed Zaki, I., Moharram Sabbah, R. (2022). 'EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS', EKB Journal Management System, 4(1), pp. 16-17. doi: 10.21608/alexpo.2022.116795.1349
El Mulla, K., Agamiaa, N., Ghazala, R., Ahmed Zaki, I., Moharram Sabbah, R. EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS. EKB Journal Management System, 2022; 4(1): 16-17. doi: 10.21608/alexpo.2022.116795.1349

EFFECT OF ISOTRETINOIN TREATMENT ON P53 EXPRESSION IN THE PILOSEBACEOUS GLANDS IN PATIENTS WITH ACNE VULGARIS

ALEXMED ePosters
Article 2, Volume 4, Issue 1, March 2022, Page 16-17  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.116795.1349
View on SCiNiTO View on SCiNiTO
Authors
Khaled Fawzy El Mulla1; Naglaa Fathi Agamiaa2; Rasha Abd El Mawla Ghazala3; Inass Ibrahim Ahmed Zaki4; Rana Mahmoud Moharram Sabbah email 2
1Department of Dermatology,Faculty of Medicine- Alexandria University
2Department of Dermatology, Faculty of Medicine- Alexandria University
3Medical Biochemistry,Faculty of Medicine- Alexandria University
4Department of Pathology, Faculty of Medicine- Alexandria University
Abstract
INTRODUCTION
Acne is one of the most common skin disorders treated by dermatologists and other health care providers. It is a chronic inflammatory skin condition.
Several drugs are used in the treatment of acne vulgaris, Isotretinoin (13-cis-retinoic acid) is the most effective drug used in the treatment of moderate to severe acne vulgaris.
Treatment with isotretinoin results in sebaceous glands shrinkage and reduced sebum production.
Many authors had suggested that the main role of systemic isotretinoin is sebocyte apoptosis in different ways. This apoptosis was hypothesized to be due to increased p53 expression.
AIM OF THE WORK
The aim of this work was to detect the effect of oral isotretinoin on the expression of p53 in tissues by immunohistochemistry, ELISA and PCR through taking skin biopsies before and after isotretinoin treatment in patients with acne vulgaris.
SUBJECTS AND METHODS
Subject:
This study was conducted on: Twenty five patients suffering from acne vulgaris. And fifteen acne-free subjects were representing controls.
The Exclusion criteria: History of intake of systemic retinoids in the last six months, Patients on antibiotic therapy in the last six months, Smoking., Female patients on anti-androgen therapy in the last six months.
Keywords
P53; ISOTRETINOIN; ACNE VULGARIS
Supplementary Files
Statistics
Article View: 76